Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |